SGH

Sivik Global Healthcare Portfolio holdings

AUM $190M
1-Year Est. Return 0.95%
This Quarter Est. Return
1 Year Est. Return
+0.95%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$190M
AUM Growth
-$33.1M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
64
New
Increased
Reduced
Closed

Top Buys

1
+$6.79M
2
+$5.48M
3
+$4.64M
4
ABBV icon
AbbVie
ABBV
+$4.63M
5
ZBH icon
Zimmer Biomet
ZBH
+$3.94M

Top Sells

1
+$10.2M
2
+$6.9M
3
+$6.28M
4
GILD icon
Gilead Sciences
GILD
+$5.54M
5
UHS icon
Universal Health Services
UHS
+$5.01M

Sector Composition

1 Healthcare 86.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZBH icon
26
Zimmer Biomet
ZBH
$18.5B
$3.94M 1.15%
+40,000
WST icon
27
West Pharmaceutical
WST
$20.3B
$3.94M 1.14%
15,000
DGX icon
28
Quest Diagnostics
DGX
$20.5B
$3.81M 1.11%
20,000
-5,000
RGEN icon
29
Repligen
RGEN
$9.32B
$3.68M 1.07%
27,500
-2,500
BIO icon
30
Bio-Rad Laboratories Class A
BIO
$8.63B
$3.08M 0.9%
11,000
-7,000
LH icon
31
Labcorp
LH
$21.7B
$2.87M 0.84%
+10,000
SEM icon
32
Select Medical
SEM
$1.86B
$2.25M 0.65%
175,000
-125,000
STVN icon
33
Stevanato
STVN
$6.26B
$2.19M 0.64%
+85,000
BRKR icon
34
Bruker
BRKR
$7.35B
$1.95M 0.57%
+60,000
GEHC icon
35
GE HealthCare
GEHC
$37.6B
$1.88M 0.55%
+25,000
ALGN icon
36
Align Technology
ALGN
$11.3B
– –
-15,000
ALNY icon
37
Alnylam Pharmaceuticals
ALNY
$61.4B
– –
-6,500
ARGX icon
38
argenx
ARGX
$56.4B
– –
-2,500
AVTR icon
39
Avantor
AVTR
$7.6B
– –
-225,000
BAX icon
40
Baxter International
BAX
$9.5B
– –
-75,000
COO icon
41
Cooper Companies
COO
$15.4B
– –
-30,000
GILD icon
42
Gilead Sciences
GILD
$152B
– –
-50,000
INSP icon
43
Inspire Medical Systems
INSP
$4.07B
– –
-10,000
MDGL icon
44
Madrigal Pharmaceuticals
MDGL
$13.4B
– –
-5,000
NVO icon
45
Novo Nordisk
NVO
$213B
– –
-100,000
RVTY icon
46
Revvity
RVTY
$11.6B
– –
-45,000
WAT icon
47
Waters Corp
WAT
$23.6B
– –
-18,000
1
2